Bone morphogenetic protein-2 release from composite hydrogels of oligo(poly(ethylene glycol) fumarate) and gelatin

Pharmaceutical Research

Volumn 30, Issue 9, 2013, Pages 2332-2343

  Kinard, Lucas A ^a   Chu, Chia Ye ^a   Tabata, Yasuhiko ^b   Kasper, F Kurtis ^a   Mikos, Antonios G ^a  

^a Rice University   (United States)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

bone morphogenetic protein 2; controlled release; gelatin microparticles; hydrogel composites; oligo(poly(ethylene glycol) fumarate)

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; FUMARIC ACID DERIVATIVE; GELATIN; OLIGO[POLY(ETHYLENE GLYCOL)FUMARATE]; TISSUE SCAFFOLD; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL PARAMETERS; COMPRESSIVE MODULUS; CONTROLLED STUDY; DEGRADATION KINETICS; DIFFUSION; DRUG DELIVERY SYSTEM; DRUG RELEASE; HYDROGEL; MASS SWELLING RATIO; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROCESS DEVELOPMENT; TISSUE ENGINEERING;

BIOCOMPATIBLE MATERIALS; BONE MORPHOGENETIC PROTEIN 2; DELAYED-ACTION PREPARATIONS; GELATIN; HYDROGELS; MATERIALS TESTING; POLYESTERS; POLYETHYLENE GLYCOLS; TISSUE ENGINEERING;

EID: 84883282704     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-013-1077-5     Document Type: Article

References (46)

1. Schantz JT, Machens HG, Schilling AF, Teoh SH. Regenerative medicine: implications for craniofacial surgery. J Craniofac Surg. 2012;23(2):530-6.
2. Kolk A, Handschel J, Drescher W, Rothamel D, Kloss F, Blessmann M, et al. Current trends and future perspectives of bone substitute materials - from space holders to innovative biomaterials. J Craniomaxillofac Surg. 2012;40(8):706-18.
3. Kretlow JD, Young S, Klouda L, Wong M, Mikos AG. Injectable biomaterials for regenerating complex craniofacial tissues. Adv Mater. 2009;21(32-33):3368- 93.
4. Rocchietta I, Fontana F, Simion M. Clinical outcomes of vertical bone augmentation to enable dental implant placement: a systematic review. J Clin Periodontol. 2008;35(8 Suppl):203-15.
5. Kinard LA, Kasper FK, Mikos AG. Synthesis of oligo(poly(ethylene glycol) fumarate). Nat Protoc. 2012;7(6):1219-27.
6. Hanada K, Dennis JE, Caplan AI. Stimulatory effects of basic fibroblast growth factor and bone morphogenetic protein-2 on osteogenic differentiation of rat bone marrow-derived mesenchymal stem cells. J Bone Miner Res. 1997;12(10):1606-14.
7. Okubo Y, Bessho K, Fujimura K, Konishi Y, Kusumoto K, Ogawa Y, et al. Osteoinduction by recombinant human bone morphogenetic protein-2 at intramuscular, intermuscular, subcutaneous and intrafatty sites. Int J Oral Surg. 2000;29(1):62-6.
8. Li RH, Wozney JM. Delivering on the promise of bone morphogenetic proteins. Trends Biotechnol. 2001;19(7):255-65.
9. Wang H, Zou Q, Boerman OC, Nijhuis AW, Jansen JA, Li Y, et al. Combined delivery of bmp-2 and bfgf from nanostructured colloidal gelatin gels and its effect on bone regeneration in vivo. J Control Release. 2013;166(2):172-81.
10. Kimura Y, Miyazaki N, Hayashi N, Otsuru S, Tamai K, Kaneda Y, et al. Controlled release of bone morphogenetic protein-2 enhances recruitment of osteogenic progenitor cells for de novo generation of bone tissue. Tissue Eng A. 2010;16(4):1263-70.
11. Brown KV, Li B, Guda T, Perrien DS, Guelcher SA, Wenke JC. Improving bone formation in a rat femur segmental defect by controlling bone morphogenetic protein-2 release. Tissue Eng A. 2011;17(13-14):1735-46.
12. Balmayor ER, Feichtinger GA, Azevedo HS, van Griensven M, Reis RL. Starch-poly-epsilon-caprolactone microparticles reduce the needed amount of bmp-2. Clin Orthop Relat Res. 2009;467(12):3138-48.
13. Jo S, Shin H, Shung AK, Fisher JP, Mikos AG. Synthesis and characterization of oligo(poly(ethylene glycol) fumarate) macromer. Macromolecules. 2001;34(9):2839-44.
14. Tabata Y, Hijikata S, Muniruzzaman M, Ikada Y. Neovascularization effect of biodegradable gelatin microspheres incorporating basic fibroblast growth factor. J Biomater Sci Polym Ed. 1999;10(1):79-94.
15. Park H, Guo X, Temenoff JS, Tabata Y, Caplan AI, Kasper FK, et al. Effect of swelling ratio of injectable hydrogel composites on chondrogenic differentiation of encapsulated rabbit marrow mesenchymal stem cells in vitro. Biomacromolecules. 2009;10(3):541-6.
16. Slotte C, Lundgren D. Impact of cortical perforations of contiguous donor bone in a guided bone augmentation procedure: an experimental study in the rabbit skull. Clin Implant Dent Relat Res. 2002;4(1):1-10.
17. Klijn RJ, van den Beucken JJ, Felix Lanao RP, Veldhuis G, Leeuwenburgh SC, Wolke JG, et al. Three different strategies to obtain porous calcium phosphate cements: comparison of performance in a rat skull bone augmentation model. Tissue Eng A. 2012;18(11-12):1171-82.
18. Temenoff JS, Park H, Jabbari E, Conway DE, Sheffield TL, Ambrose CG, et al. Thermally cross-linked oligo(poly(ethylene glycol) fumarate) hydrogels support osteogenic differentiation of encapsulated marrow stromal cells in vitro. Biomacromolecules. 2004;5(1):5-10.
19. Peppas NA. Hydrogels in medicine and pharmacy. Boca Raton: CRC Press; 1986.
20. Dadsetan M, Pumberger M, Casper ME, Shogren K, Giuliani M, Ruesink T, et al. The effects of fixed electrical charge on chondrocyte behavior. Acta Biomater. 2011;7(5):2080-90.
21. Patel ZS, Yamamoto M, Ueda H, Tabata Y, Mikos AG. Biodegradable gelatin microparticles as delivery systems for the controlled release of bone morphogenetic protein-2. Acta Biomater. 2008;4(5):1126-38.
22. Ritger PL, Peppas NA. A simple equation for description of solute release i. Fickian and non-fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs. J Control Release. 1987;5(1):23-36.
23. Holland TA, Tabata Y, Mikos AG. In vitro release of transforming growth factor-beta 1 from gelatin microparticles encapsulated in biodegradable, injectable oligo(poly(ethylene glycol) fumarate) hydrogels. J Control Release. 2003;91(3):299-313.
24. Holland TA, Tabata Y, Mikos AG. Dual growth factor delivery from degradable oligo(poly(ethylene glycol) fumarate) hydrogel scaffolds for cartilage tissue engineering. J Control Release. 2005;101(1-3):111-25.
25. Shin H, Quinten Ruhe P, Mikos AG, Jansen JA. In vivo bone and soft tissue response to injectable, biodegradable oligo(poly(ethylene glycol) fumarate) hydrogels. Biomaterials. 2003;24(19):3201-11.
26. Temenoff JS, Park H, Jabbari E, Sheffield TL, LeBaron RG, Ambrose CG, et al. In vitro osteogenic differentiation of marrow stromal cells encapsulated in biodegradable hydrogels. J Biomed Mater Res A. 2004;70(2):235-44.
27. Holland TA, Tessmar JKV, Tabata Y, Mikos AG. Transforming growth factor-beta 1 release from oligo(poly(ethylene glycol) fumarate) hydrogels in conditions that model the cartilage wound healing environment. J Control Release. 2004;94(1):101-14.
28. Nuno-Donlucas SM, Sanches-Diaz JC, Rabelero M, Cortes-Ortega J, Luhrs-Olmos CC, Fernandez-Escamilla VV, et al. Microstructured polyacrylamide hydrogels made with hydrophobic nanoparticles. J Colloid Interface Sci. 2004;270(1):94-8.
29. Zhang XZ, Lewis PJ, Chu CC. Fabrication and characterization of a smart drug delivery system: microsphere in hydrogel. Biomaterials. 2005;26(16):3299-309.
30. Habraken WJEM, de Jonge LT, Wolke JGC, Yubao L, Mikos AG, Jansen JA. Introduction of gelatin microspheres into an injectable calcium phosphate cement. J Biomed Mater Res A. 2008;87A(3):643-55.
31. Dadsetan M, Hefferan TE, Szatkowski JP, Mishra PK, Macura SI, Lu L, et al. Effect of hydrogel porosity on marrow stromal cell phenotypic expression. Biomaterials. 2008;29(14):2193-202.
32. Shin H, Temenoff JS, Bowden GC, Zygourakis K, Farach-Carson MC, Yaszemski MJ, et al. Osteogenic differentiation of rat bone marrow stromal cells cultured on arg-gly-asp modified hydrogels without dexamethasone and beta-glycerol phosphate. Biomaterials. 2005;26(17):3645-54.
33. Shin H, Zygourakis K, Farach-Carson MC, Yaszemski MJ, Mikos AG. Attachment, proliferation, and migration of marrow stromal osteoblasts cultured on biomimetic hydrogels modified with an osteopontin-derived peptide. Biomaterials. 2004;25(5):895-906.
34. Yamamoto M, Tabata Y, Hong L, Miyamoto S, Hashimoto N, Ikada Y. Bone regeneration by transforming growth factor beta 1 released from a biodegradable hydrogel. J Control Release. 2000;64(1-3):133-42.
35. Guo X, Park H, Young S, Kretlow JD, van den Beucken JJ, Baggett LS, et al. Repair of osteochondral defects with biodegradable hydrogel composites encapsulating marrow mesenchymal stem cells in a rabbit model. Acta Biomater. 2010;6(1):39-47.
36. Holland TA, Bodde EWH, Baggett LS, Tabata Y, Mikos AG, Jansen JA. Osteochondral repair in the rabbit model utilizing bilayered, degradable oligo(poly(ethylene glycol) fumarate) hydrogel scaffolds. J Biomed Mater Res A. 2005;75A(1):156-67.
37. Holland TA, Bodde EWH, Cuijpers VMJI, Baggett LS, Tabata Y, Mikos AG, et al. Degradable hydrogel scaffolds for in vivo delivery of single and dual growth factors in cartilage repair. Osteoarthr Cartil. 2007;15(2):187-97.
38. Yamamoto M, Ikada Y, Tabata Y. Controlled release of growth factors based on biodegradation of gelatin hydrogel. J Biomater Sci Polym Ed. 2001;12(1):77-88.
39. Young S, Patel ZS, Kretlow JD, Murphy MB, Mountziaris PM, Baggett LS, et al. Dose effect of dual delivery of vascular endothelial growth factor and bone morphogenetic protein-2 on bone regeneration in a rat critical-size defect model. Tissue Eng A. 2009;15(9):2347-62.
40. Cowan CM, Aghaloo T, Chou YF, Walder B, Zhang XL, Soo C, et al. Microct evaluation of three-dimensional mineralization in response to bmp-2 doses in vitro and in critical sized rat calvarial defects. Tissue Eng. 2007;13(3):501-12.
41. Annabi N, Nichol JW, Zhong X, Ji C, Koshy S, Khademhosseini A, et al. Controlling the porosity and microarchitecture of hydrogels for tissue engineering. Tissue Eng B. 2010;16(4):371-83.
42. Whang K, Healy KE, Elenz DR, Nam EK, Tsai DC, Thomas CH, et al. Engineering bone regeneration with bioabsorbable scaffolds with novel microarchitecture. Tissue Eng. 1999;5(1):35-51.
43. Karageorgiou V, Kaplan D. Porosity of 3d biomaterial scaffolds and osteogenesis. Biomaterials. 2005;26(27):5474-91.
44. Patel ZS, Ueda H, Yamamoto M, Tabata Y, Mikos AG. In vitro and in vivo release of vascular endothelial growth factor from gelatin microparticles and biodegradable composite scaffolds. Pharm Res. 2008;25(10):2370-8.
45. Kim K, Lam J, Lu S, Spicer PP, Lueckgen A, Tabata Y, et al. Osteochondral tissue regeneration using a bilayered composite hydrogel with modulating dual growth factor release kinetics in a rabbit model. J Control Release. 2013;168(2):166-78.
46. Crank J. The mathematics of diffusion. 2nd ed. New York: Oxford University Press; 1975.